Silo Pharma Inc.

NASDAQ: SILO · Real-Time Price · USD
0.71
0.00 (0.00%)
At close: Aug 18, 2025, 2:46 PM

Silo Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-4.39M -3.7M -3.91M 3.9M
Depreciation & Amortization
6.18K n/a n/a 107.97K
Stock-Based Compensation
n/a 104.19K 156.05K 191.7K
Other Working Capital
551.76K -36.41K -21.57K 730.92K
Other Non-Cash Items
1.02K 72.72K 330.17K -7.1M
Deferred Income Tax
n/a n/a n/a -107.97K
Change in Working Capital
551.76K 299.27K -75.29K 729.71K
Operating Cash Flow
-3.83M -3.22M -3.5M -2.28M
Capital Expenditures
4.00 n/a n/a -4
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-175.54K -4.15M n/a n/a
Sales Maturities Of Investments
1.15M n/a 66.71K 7.02M
Other Investing Acitivies
n/a n/a 20K 172K
Investing Cash Flow
973.78K -4.15M 86.71K 7.19M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-173.11K -471.12K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.00 n/a n/a n/a
Financial Cash Flow
3.24M -471.12K 4.94M 3.79M
Net Cash Flow
381.49K -7.84M 1.53M 8.71M
Free Cash Flow
-3.83M -3.22M -3.5M -2.28M